Are you looking for a little exposure to the small side of the market? If you are, you might want to add the small cap ASX shares listed below to your watchlists.
I think all three have the potential to be stars of the future. Here's why I like them:
Alcidion Group Ltd (ASX: ALC)
Alcidion is a $150 million healthcare informatics solutions company. It provides software which has been designed to improve the efficacy and cost of delivering services to patients and reduce hospital-acquired complications. The company has a number of software solutions being used by healthcare institutions across the ANZ and UK. These include the Patientrack patient safety and communications system and the Miya Precision health analytics platform.
Clover Corporation Limited (ASX: CLV)
Clover is a $375 million specialist ingredients producer. It produces ingredients such as the highly sought-after omega-3 oils that go into infant formula, supplements, and baby food products. Clover has been growing at a strong rate over the last few years thanks largely to the increasing demand for ingredients from infant formula market. The good news is that this strong growth looks likely to continue over the coming years thanks to favourable changes to ingredient requirements in a number of key markets. This could make Clover a small cap to watch.
Mach7 Technologies Ltd (ASX: M7T)
Mach7 is a $230 million medical imaging data management solutions provider. It provides an Enterprise Imaging Platform that unlocks disparate archive silos, consolidates patient data, and simplifies sharing and access. This allows users to improve patient care, reach compliance goals, and deliver clinical and operational decision support enterprise wide. The company has also recently announced the acquisition of Client Outlook. Not only has the acquisition of the leading provider of enterprise image viewing technology bolstered its offering, it has lifted its total addressable market by US$2 billion to US$2.75 billion.
